Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy

Anne Rietz, Hongxia Li, Kevin M. Quist, Jonathan J. Cherry, Christian L. Lorson, Barrington G. Burnett, Nicholas L. Kern, Alyssa N. Calder, Melanie Fritsche, Hrvoje Lusic, Patrick J. Boaler, Sungwoon Choi, Xuechao Xing, Marcie A. Glicksman, Gregory D. Cuny, Elliot Androphy, Kevin J. Hodgetts

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Spinal muscular atrophy (SMA) is the leading genetic cause of infant death. We previously developed a high-throughput assay that employs an SMN2-luciferase reporter allowing identification of compounds that act transcriptionally, enhance exon recognition, or stabilize the SMN protein. We describe optimization and characterization of an analog suitable for in vivo testing. Initially, we identified analog 4m that had good in vitro properties but low plasma and brain exposure in a mouse PK experiment due to short plasma stability; this was overcome by reversing the amide bond and changing the heterocycle. Thiazole 27 showed excellent in vitro properties and a promising mouse PK profile, making it suitable for in vivo testing. This series post-translationally stabilizes the SMN protein, unrelated to global proteasome or autophagy inhibition, revealing a novel therapeutic mechanism that should complement other modalities for treatment of SMA.

Original languageEnglish (US)
Pages (from-to)4594-4610
Number of pages17
JournalJournal of Medicinal Chemistry
Volume60
Issue number11
DOIs
StatePublished - Jun 8 2017

Fingerprint

Spinal Muscular Atrophy
Motor Neurons
Thiazoles
Autophagy
Proteasome Endopeptidase Complex
Luciferases
Amides
Cause of Death
Exons
Proteins
Brain
In Vitro Techniques
Therapeutics
Infant Death

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. / Rietz, Anne; Li, Hongxia; Quist, Kevin M.; Cherry, Jonathan J.; Lorson, Christian L.; Burnett, Barrington G.; Kern, Nicholas L.; Calder, Alyssa N.; Fritsche, Melanie; Lusic, Hrvoje; Boaler, Patrick J.; Choi, Sungwoon; Xing, Xuechao; Glicksman, Marcie A.; Cuny, Gregory D.; Androphy, Elliot; Hodgetts, Kevin J.

In: Journal of Medicinal Chemistry, Vol. 60, No. 11, 08.06.2017, p. 4594-4610.

Research output: Contribution to journalArticle

Rietz, A, Li, H, Quist, KM, Cherry, JJ, Lorson, CL, Burnett, BG, Kern, NL, Calder, AN, Fritsche, M, Lusic, H, Boaler, PJ, Choi, S, Xing, X, Glicksman, MA, Cuny, GD, Androphy, E & Hodgetts, KJ 2017, 'Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy', Journal of Medicinal Chemistry, vol. 60, no. 11, pp. 4594-4610. https://doi.org/10.1021/acs.jmedchem.6b01885
Rietz, Anne ; Li, Hongxia ; Quist, Kevin M. ; Cherry, Jonathan J. ; Lorson, Christian L. ; Burnett, Barrington G. ; Kern, Nicholas L. ; Calder, Alyssa N. ; Fritsche, Melanie ; Lusic, Hrvoje ; Boaler, Patrick J. ; Choi, Sungwoon ; Xing, Xuechao ; Glicksman, Marcie A. ; Cuny, Gregory D. ; Androphy, Elliot ; Hodgetts, Kevin J. / Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. In: Journal of Medicinal Chemistry. 2017 ; Vol. 60, No. 11. pp. 4594-4610.
@article{7a0b35a62ed64676b4443448a6599d55,
title = "Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy",
abstract = "Spinal muscular atrophy (SMA) is the leading genetic cause of infant death. We previously developed a high-throughput assay that employs an SMN2-luciferase reporter allowing identification of compounds that act transcriptionally, enhance exon recognition, or stabilize the SMN protein. We describe optimization and characterization of an analog suitable for in vivo testing. Initially, we identified analog 4m that had good in vitro properties but low plasma and brain exposure in a mouse PK experiment due to short plasma stability; this was overcome by reversing the amide bond and changing the heterocycle. Thiazole 27 showed excellent in vitro properties and a promising mouse PK profile, making it suitable for in vivo testing. This series post-translationally stabilizes the SMN protein, unrelated to global proteasome or autophagy inhibition, revealing a novel therapeutic mechanism that should complement other modalities for treatment of SMA.",
author = "Anne Rietz and Hongxia Li and Quist, {Kevin M.} and Cherry, {Jonathan J.} and Lorson, {Christian L.} and Burnett, {Barrington G.} and Kern, {Nicholas L.} and Calder, {Alyssa N.} and Melanie Fritsche and Hrvoje Lusic and Boaler, {Patrick J.} and Sungwoon Choi and Xuechao Xing and Glicksman, {Marcie A.} and Cuny, {Gregory D.} and Elliot Androphy and Hodgetts, {Kevin J.}",
year = "2017",
month = "6",
day = "8",
doi = "10.1021/acs.jmedchem.6b01885",
language = "English (US)",
volume = "60",
pages = "4594--4610",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy

AU - Rietz, Anne

AU - Li, Hongxia

AU - Quist, Kevin M.

AU - Cherry, Jonathan J.

AU - Lorson, Christian L.

AU - Burnett, Barrington G.

AU - Kern, Nicholas L.

AU - Calder, Alyssa N.

AU - Fritsche, Melanie

AU - Lusic, Hrvoje

AU - Boaler, Patrick J.

AU - Choi, Sungwoon

AU - Xing, Xuechao

AU - Glicksman, Marcie A.

AU - Cuny, Gregory D.

AU - Androphy, Elliot

AU - Hodgetts, Kevin J.

PY - 2017/6/8

Y1 - 2017/6/8

N2 - Spinal muscular atrophy (SMA) is the leading genetic cause of infant death. We previously developed a high-throughput assay that employs an SMN2-luciferase reporter allowing identification of compounds that act transcriptionally, enhance exon recognition, or stabilize the SMN protein. We describe optimization and characterization of an analog suitable for in vivo testing. Initially, we identified analog 4m that had good in vitro properties but low plasma and brain exposure in a mouse PK experiment due to short plasma stability; this was overcome by reversing the amide bond and changing the heterocycle. Thiazole 27 showed excellent in vitro properties and a promising mouse PK profile, making it suitable for in vivo testing. This series post-translationally stabilizes the SMN protein, unrelated to global proteasome or autophagy inhibition, revealing a novel therapeutic mechanism that should complement other modalities for treatment of SMA.

AB - Spinal muscular atrophy (SMA) is the leading genetic cause of infant death. We previously developed a high-throughput assay that employs an SMN2-luciferase reporter allowing identification of compounds that act transcriptionally, enhance exon recognition, or stabilize the SMN protein. We describe optimization and characterization of an analog suitable for in vivo testing. Initially, we identified analog 4m that had good in vitro properties but low plasma and brain exposure in a mouse PK experiment due to short plasma stability; this was overcome by reversing the amide bond and changing the heterocycle. Thiazole 27 showed excellent in vitro properties and a promising mouse PK profile, making it suitable for in vivo testing. This series post-translationally stabilizes the SMN protein, unrelated to global proteasome or autophagy inhibition, revealing a novel therapeutic mechanism that should complement other modalities for treatment of SMA.

UR - http://www.scopus.com/inward/record.url?scp=85020408930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020408930&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.6b01885

DO - 10.1021/acs.jmedchem.6b01885

M3 - Article

C2 - 28481536

AN - SCOPUS:85020408930

VL - 60

SP - 4594

EP - 4610

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 11

ER -